You are here: Industry Insights > Moderna

News List

Moderna’s new Covid-19 vaccine production facility gets EMA approval pharmaceutical-technology
June 15, 2021
Moderna has received the European Medicines Agency’s (EMA) committee for human medicines (CHMP) approval for a new production facility in Monts, France, to manufacture its Covid-19 vaccine.
Rafael Holdings Announces Appointments to its Board of Directors firstwordpharma
June 15, 2021
Rafael Holdings, Inc., (NYSE: RFL), today announced the appointment of three senior biopharmaceutical leaders to its Board of Directors: Ameet Mallik, Chief Executive Officer of Rafael Holdings; Shannon Thyme Klinger, Chief Legal Officer of Moderna, Inc..
EMA to assess whether COVID-19 Vaccine Moderna can be used in adolescents europeanpharmaceuticalreview
June 10, 2021
The European Medicines Agency (EMA) has begun evaluating whether to extend the use of the COVID-19 Vaccine Moderna to include adolescents aged 12 to 17.
Moderna and Medison Pharma Partner to Commercialize Moderna's COVID-19 Vaccine Across Central Eastern Europe and Israel americanpharmaceuticalreview
June 09, 2021
Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Medison Pharma, a leading commercial partner for highly innovative therapies in international markets, announced a new agreement to commercialize the ...
Moderna enters drug substance production deal with Lonza pharmaceutical-technology
June 04, 2021
Moderna has signed a new agreement with Lonza to create a new production line at the latter’s Geleen facility in the Netherlands, which will support drug substance production for its international supply chain.
Cipla seeks clarity, guidance from Govt for import of COVID-19 vaccine expresspharma
June 03, 2021
The company is seeking fast-track approvals to expeditiously bring Moderna's single-dose COVID-19 booster vaccine into India.
Lonza, Moderna Expand COVID Vax Mfg. Alliance contractpharma
June 03, 2021
Lonza to support the manufacture of up to an additional 300 million doses per year with install of a new manufacturing line at The Netherlands site.
Moderna Announces Agreement with Thermo Fisher Scientific for Fill/Finish Manufacturing of Moderna’s COVID-19 Vaccine firstwordpharma
June 02, 2021
Moderna, Inc. today announced that it has entered into an agreement with Thermo Fisher Scientific (NYSE: TMO) for fill/finish sterile manufacturing services and supply packaging for Moderna's COVID-19 vaccine.
Cipla says close to committing $1 billion to Moderna for booster vaccine firstwordpharma
June 01, 2021
Sources say Cipla has asked the Indian government for indemnification and exemptions from price capping, bridging trials and basic customs duty, as the company seeks fast-track approvals to bring Moderna's single-dose COVID-19 booster vaccine.
Moderna’s COVID-19 vaccine 93 percent effective in adolescents europeanpharmaceuticalreview
May 28, 2021
New Phase II/III study data shows Moderna’s COVID-19 vaccine is safe and immunogenic in patients aged 12 to less than 18 years old.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page